Captions will be available by Sept. 20th.
This workshop will focus on the need for standards to support the burgeoning biotech and pharma industries developing clinical applications that target the human microbiome. Informed regulatory decision making requires an understanding of the analytical performance of the assays being used to verify the identity, purity, potency and stability of these biomanufactured Live Biotherapeutic Products (LBPs). Additionally, clinical microbiome laboratory tests must be validated before being used for donor screening, monitoring engraftment or evaluating other changes that occur in a patient’s microbiome before, during and after therapeutic intervention.
While next generation sequencing (NGS)-based (metagenomic) methods will be a major emphasis, other analytical methods, such as those being used for enumeration and viability assessment, will also be addressed.
NIST is currently working with our stakeholder community to develop standards for microbiome measurements that will enable federal, academic and industry labs to reliably reproduce each other’s results and advance the overall field.
Ricardo Valladares, Siolta
Dana Walsh, Rebiotix
Kit Goldman, USP
Paul Carlson, FDA/CBER
Jeffrey Heiser, Boston Analytical
Jennifer Balkus, University of Washington
Scott Tighe, University of Vermont
Dieter Tourlousse, AIST
Gregory C A Amos, NIBSC
Phil McQueen, NIH Center for Information Technology
Agenda Updated 9/4
8:00 AM Registration, Poster Set-up, Exhibitor Set-up, Continental Breakfast
9:00 AM Welcome and Introduction Scott Jackson, NIST Eric Lin, Director, Material Measurement Laboratory, NIST
SESSION 1: LIVE BIOTHERAPEUTIC PRODUCTS
9:35 AM Ricardo Valladares, Siolta Therapeutics
9:55 AM Dana Walsh, Rebiotix
10:15 AM Poster and Refreshment Break
10:45 AM Kit Goldman, USP
11:05 AM Paul Carlson, FDA/CBER
11:25 AM Jeffrey Heiser, Boston Analytical
11:45 AM PANEL DISCUSSION: Manufacturing Hurdles for LBPs
12:45 PM LUNCH
1:45 PM Sheila Dreher-Lesnick, FDA/CBER
SESSION 2: MICROBIAL METROLOGY AT NIST
2:05 PM NIST Speakers
3:05 PM Poster and Refreshment Break
SESSION 3: CONSORTIA MODELS
3:35 PM Elisha Wood-Charlson, Dept of Energy Systems Biology Knowledgebase (KBase)
3:45 PM NIST Consortia Models
4:15 PM PANEL DISCUSSION: Consortium
5:25 PM Closing Remarks Scott Jackson, NIST
5:30 PM ADJOURN
8:30 AM Continental Breakfast
9:00 AM Opening Remarks
SESSION 4: CLINICAL METAGENOMICS
9:05 AM Raja Mazumder, GWU
9:25 AM Brittney Goldberg, FDA/CDRH
9:45 AM Lightning Talks
10:10 AM Poster and Refreshment Break
SESSION 5: DATA ANALYTICS
10:40 AM Daryl Gohl, University of Minnesota Genomics Center
11:00 AM Jennifer Barb and Phil McQueen, NIH
11:20 AM Ben Callahan, NC State
11:40 AM PANEL DISCUSSION: Data Analytics
12:30 PM LUNCH
SESSION 6: STANDARDS FOR MICROBIOME PRODUCTS
1:30 PM Scott Jackson, NIST
1:50 PM Raul Cano, The BioCollective
2:10 PM Gregory C A Amos, NIBSC
2:30 PM Jennifer Balkus, University of Washington
2:50 PM Poster and Refreshment Break
3:20 PM Christian Abnet, NIH/NCI
3:40 PM Scott Tighe, University of Vermont
4:00 PM Dieter Tourlousse, AIST
4:20 PM PANEL DISCUSSION: Standards for Microbiome Products
5:10 PM Concluding Remarks Scott Jackson, NIST
5:15 PM ADJOURN
Courtyard Marriott Washingtonian Center - Gaithersburg
204 Boardwalk Place Gaithersburg, Maryland 20878
The Marriott offers a complimentary shuttle to and from NIST.
From $199/per night
Start Date: Sunday, September 8, 2019 |
End Date: Thursday, September 12, 2019 |
Last Day to Book: Monday, August 5, 2019 |
If you are not registered, you will not be allowed on site. Registered attendees will receive security and campus instructions prior to the workshop.
NON U.S. CITIZENS PLEASE NOTE: All foreign national visitors who do not have permanent resident status and who wish to register for the above meeting must supply additional information. Failure to provide this information prior to arrival will result, at a minimum, in significant delays in entering the facility. Authority to gather this information is derived from United States Department of Commerce Department Administrative Order (DAO) number 207-12.
NIST currently accepts the following forms of federally issued identification in lieu of a state-issued driver's license, such as a valid passport, passport card, DOD's Common Access Card (CAC), Veterans ID, Federal Agency HSPD-12 IDs, Military Dependents ID, Transportation Workers Identification Credential (TWIC), and TSA Trusted Traveler ID.
U.S. Residents: New Visitor Access Requirement: Effective July 21, 2014, under the REAL ID Act of 2005, agencies, including NIST, can only accept a state-issued driver's license or identification card from states that are REAL ID compliant or have an extension. See the Department of Homeland Security (DHS) site for the current compliance list